Poultry medicine market is gaining importance in the global animal health market owing to the growth in poultry production and increased focus on disease prevention, efficiency and biosecurity among poultry farmers. Poultry medicines are composed of pharmaceutical products, biologicals, vaccines, antiparasitic products and other health-related products used in the prevention and treatment of diseases in chickens, ducks, and other poultry birds. Increasing consumption of poultry meat, prevalence of diseases, commercial farming activities and adoption of precision livestock technology is driving the growth of this market.
According to the SNS Insider, the Poultry Medicine Market was valued at USD 6.65 billion in 2024 and is predicted to rise to USD 11.22 billion in 2032 with a growth rate of 6.77% between 2025-2032. Rising poultry production, increased incidence of infectious diseases, increasing awareness about preventative medicine, and technological innovations in the field of poultry health management are contributing towards the development of the market. Precision livestock farming technologies, veterinary digital platforms, and mobile apps have enabled the producers to detect health issues in an early stage and maintain flock records.
Gain Actionable Intelligence on Poultry Medicine Market – Request a Sample Report
Top 3 Poultry Medicine Companies
1. Zoetis Inc.
Zoetis Inc. is one of the top animal health firms contributing to the development of the poultry medication market through its extensive range of vaccines, drugs, and diagnostics. The firm’s poultry health products are aimed at ensuring that the producers prevent the emergence of diseases in their flocks, boost their productivity, and minimize the financial damage due to deaths and decreased productivity levels. Its prominent global presence and emphasis on preventive animal health care make Zoetis Inc. well-placed to capitalize on the increasing shift to vaccinations, disease monitoring, and scientific poultry management.
2. Boehringer Ingelheim Animal Health
Boehringer Ingelheim Animal Health has created a solid footing in poultry health through vaccines and technology that helps achieve disease prevention and flock management. The company offers solutions for most poultry diseases, and increasingly uses technology to assist farmers in optimizing their vaccination programs as well as monitoring the health of flocks. In January 2025, Boehringer Ingelheim Animal Health introduced a digital monitoring system that will assist the use of Gallivac® vaccine program. The digital monitoring system aims at improving the vaccine immunization process while reducing vaccine inefficiency in the field.
3. Merck Animal Health
Merck Animal Health is one of the leading participants of the poultry medicines market, providing vaccines, pharmaceuticals, diagnostics and digital health tools for commercial poultry farmers. The company's product range includes tools to prevent diseases and monitor health status in various production conditions. In April 2024, Merck launched its new FLOCKSECURE™ Poultry Health Portal – an online platform for gathering, storing, distributing and analyzing information about post-mortem examination. The launch demonstrates the trend in the industry towards data-based poultry health management. In March 2025, the company also launched a more advanced Innovax® ND-IBD recombinant vaccine to protect birds from Newcastle Disease and Infectious Bursal Disease.
What is Driving the Future of the Poultry Medicine Market?
One of the major factors that fuel the growth of the market is the increasing incidence of infectious diseases in poultry. The diseases like Newcastle disease, avian influenza, coccidiosis, and Infectious bronchitis can spread quickly in the commercial farms where the animals are raised at high density, causing mortality and losses. Due to this, the use of vaccines and pharmaceutical products has increased among the poultry farmers.
Technological innovations have been contributing to the development of poultry health management through providing producers with better means of tracking the health status of the flock in a more effective manner. The use of precision livestock farming, technological monitoring systems, veterinary mobile applications, and data analysis helps in providing relevant information on poultry health status, behavior, and conditions. It enables producers to make decisions on treatment that will ensure proper disease management without the use of unnecessary drugs. Moreover, such technological innovations can contribute to better biosecurity measures and promote animal welfare standards as well.
Injection-based drugs dominated the route of administration, contributing to 50.23% of the share in 2024 due to their accurate dosing, faster action and application in vaccination programs. On the other hand, ocular and intranasal methods are showing rapid growth at CAGR 7.59% as they offer non-invasive routes of drug delivery ideal for mass immunization especially in large flock of poultry birds. The Newcastle Disease dominates the disease category due to its high transmissibility along with the potential to cause mortalities and lower production. Along with this, other disease segments are showing rapid growth due to diversified poultry production involving ducks, turkey, and quails.
The Road Ahead
The market for Poultry Medicine will be positively impacted by ongoing developments in preventive healthcare, vaccines, technology and precise livestock farming. As there is an increasing fear of infection, the rise in antimicrobial resistance, food safety issues and animal welfare, poultry farmers will find that it is increasingly important to implement a more precise and scientific approach to their health care needs. With the incorporation of artificial intelligence, data analysis, mobile veterinary applications and real time monitoring, better disease detection and medication usage will be achieved. Meanwhile, there will be an advancement in recombinant, in ovo and other types of vaccines that will ensure disease prevention without using medicines.
In the future, another important influence on the market will be the modernization of the commercial poultry farming and the necessity of efficient flock management. More and more producers are looking for poultry medications which ensure disease protection and productivity, biosecurity, and sustainable production. Increased knowledge on the part of small farmers, better education of veterinarians, and closer cooperation of animal health companies with poultry producers could increase access to modern health solutions. Those companies which invest in biologics, digital health systems, species-specific medicines, and disease management solutions will certainly benefit from changes in the global poultry industry.
